New FDA Regulation on Laboratory Developed Tests Draws Objections from Healthcare Groups
source: shutterstock.com

New FDA Regulation on Laboratory Developed Tests Draws Objections from Healthcare Groups

As reported in Biopharma Dive, the FDA’s decision to strengthen its authority involving laboratory developed tests (LDTs) has drawn considerable objections from various healthcare groups. However, the Agency has held…

Continue Reading New FDA Regulation on Laboratory Developed Tests Draws Objections from Healthcare Groups
Scientists have Discovered a Connection Between Metabolic Problems in the Brain and Neurological Disorders
source: shutterstock.com

Scientists have Discovered a Connection Between Metabolic Problems in the Brain and Neurological Disorders

  These efforts led to collaboration by the International Brain pH Project that involves 131 scientists in 105 labs from seven countries. The scientists have identified changes in lactate levels…

Continue Reading Scientists have Discovered a Connection Between Metabolic Problems in the Brain and Neurological Disorders
Science Simplified: Differences Between a Gene Therapy Clinical Trial and a Cure
source: pixabay.com

Science Simplified: Differences Between a Gene Therapy Clinical Trial and a Cure

Want to learn about scientific topics without needing a PhD? Check out the Science Simplified blog from TESS Research Foundation! Dr. Tanya Brown, PhD, works with researchers to make science…

Continue Reading Science Simplified: Differences Between a Gene Therapy Clinical Trial and a Cure
Doctors Transplant Genetically Edited Pig Kidney Into 62-Year-Old Man with End-Stage Kidney Disease
source: shutterstock.com

Doctors Transplant Genetically Edited Pig Kidney Into 62-Year-Old Man with End-Stage Kidney Disease

Over 100,000 individuals living in the U.S. are on a waiting list for an organ transplant. An average of 17 people die each day while waiting for a donor organ.…

Continue Reading Doctors Transplant Genetically Edited Pig Kidney Into 62-Year-Old Man with End-Stage Kidney Disease
Highlights of ACMG 2024
source: shutterstock.com

Highlights of ACMG 2024

Perhaps 70- 85% of rare diseases have a root in genetics, - which is why continuous research and reporting is so critical for those with rare conditions. This is exactly…

Continue Reading Highlights of ACMG 2024
Study Lists Neurological Disease as the Top Cause of Disability and Illness Around the World
source: shutterstock.com

Study Lists Neurological Disease as the Top Cause of Disability and Illness Around the World

Neurological conditions now have the highest rates of disability and ill health worldwide. The Disparity Although more than 80% of the neurological deaths and nervous system disorders occur in lower…

Continue Reading Study Lists Neurological Disease as the Top Cause of Disability and Illness Around the World
Rare Community Profiles: Yellow for Yiannis: Angela’s Mission to Advance Research into IRF2BPL
Fotocitizen / Pixabay

Rare Community Profiles: Yellow for Yiannis: Angela’s Mission to Advance Research into IRF2BPL

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: Yellow for Yiannis: Angela’s Mission to Advance Research into IRF2BPL
Rare Community Profiles: A Potential Treatment Turning Point for ALK-Positive NSCLC: Dr. Ken Culver Shares Insights from the Phase 3 ALINA Study on Alecensa
Photo by Robina Weermeijer on Unsplash

Rare Community Profiles: A Potential Treatment Turning Point for ALK-Positive NSCLC: Dr. Ken Culver Shares Insights from the Phase 3 ALINA Study on Alecensa

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: A Potential Treatment Turning Point for ALK-Positive NSCLC: Dr. Ken Culver Shares Insights from the Phase 3 ALINA Study on Alecensa
American College of Medical Genetics and Genomics 2024: Advances Promise a Better Future for Rare Disease Patients
source: shutterstock.com

American College of Medical Genetics and Genomics 2024: Advances Promise a Better Future for Rare Disease Patients

The overwhelming majority of rare diseases and conditions have a genetic basis. This means that the disease is the result of a genetic abnormality such as a mutation. These abnormalities…

Continue Reading American College of Medical Genetics and Genomics 2024: Advances Promise a Better Future for Rare Disease Patients
An International Team of Scientists Discovered How Pneumococcal Bacteria is Destroyed After Vaccination
source: pixabay.com

An International Team of Scientists Discovered How Pneumococcal Bacteria is Destroyed After Vaccination

For years, scientists have attempted to discover what destroys pneumococcal bacteria after a person has been vaccinated. In a recent study, vaccinologists in the U.S., China, and Switzerland, found the…

Continue Reading An International Team of Scientists Discovered How Pneumococcal Bacteria is Destroyed After Vaccination
Rare Community Profiles: A Hidden Agony: Why James is Shedding Light on Geniculate Neuralgia and its Impact on Daily Life
Fotocitizen / Pixabay

Rare Community Profiles: A Hidden Agony: Why James is Shedding Light on Geniculate Neuralgia and its Impact on Daily Life

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: A Hidden Agony: Why James is Shedding Light on Geniculate Neuralgia and its Impact on Daily Life